🔎 Trials Near Me

Почетна › Колоректални карцином › Охајо › Cleveland

Kliničke studije za Колоректални карцином u gradu Cleveland, OH

25 studija za Колоректални карцином traži učesnike na lokacijama u gradu Cleveland i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

Тражи се учесникФаза 2
  • Case Western, University Hospitals Cleveland Medical Center, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07659795

The Vanguard Study: Testing a New Way to Screen for Cancer

Тражи се учесникЗдраве особе су добродошле
  • Louis Stokes Cleveland VA Medical Center, Cleveland
Узраст од 45 до 75 · Оба пола · Ажурирано 6. 11. 2026. · NCT06995898

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

Тражи се учесникФаза 3
  • Clinical Study Site, Cleveland
  • Clinical Study Site, Cleveland
  • Clinical Study Site, Mayfield Heights · 12 ми удаљено
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07228832

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Тражи се учесникФаза 2
  • Cleveland Clinic - Oncology Department, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06760819

Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

Тражи се учесникФаза 1/2
  • University Hospitals Cleveland Medical Center, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07397338

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

Тражи се учесникФаза 3
  • University Hospitals Cleveland Medical Center, Cleveland
  • Cleveland Clinic Cancer Center Fairview Hospital Moll Pavilion, Cleveland
  • Taussig Cancer Insititute Cleveland Clinic, Cleveland
  • и још 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06662786

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

Тражи се учесникФаза 3
  • University Hospital of Cleveland, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06750094

A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies

Тражи се учесникФаза 1
  • UH Cleveland Medical Center, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07542704

A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

Тражи се учесникФаза 1
  • Cleveland Clinic, Taussig Cancer Institute, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06720987

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

Тражи се учесникФаза 1/2
  • Cleveland Clinic, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT03526835

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

Тражи се учесникФаза 3
  • Case Comprehensive Cancer Center, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT07284849

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Тражи се учесникФаза 1
  • University Hospitals - UH Cleveland Medical Center, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT07094204

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Тражи се учесникФаза 1/2
  • Cleveland Clinic, Cleveland
Узраст од 18 до 90 · Оба пола · Ажурирано 28. 10. 2026. · NCT06710756

JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration

Тражи се учесникФаза 1/2
  • Cleveland Clinic Foundation, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT06973564

Testing for Safety and Colorectal Cancer Preventive Effects of ONC201

Тражи се учесникФаза 1
  • Cleveland Clinic Foundation, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 15. 10. 2026. · NCT05630794

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Тражи се учесникФаза 1/2
  • Cleveland Clinic, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT05786924

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Тражи се учесникФаза 3
  • University Hospitals Cleveland Medical Center, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07222800

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Тражи се учесникФаза 1/2
  • University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland
  • Cleveland Clinic, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 7. 10. 2026. · NCT05919264

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

Тражи се учесникФаза 1
  • Cleveland Clinic, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT04429542

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Тражи се учесникФаза 1/2
  • The Cleveland Clinic Taussig Cancer Center, Cleveland
Узраст 12 и старији · Оба пола · Ажурирано 2. 10. 2026. · NCT04585750

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Тражи се учесникФаза 1
  • Exelixis Clinical Site #10, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 1. 10. 2026. · NCT05176483

A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer

Тражи се учесникФаза 1/2
  • Cleveland Clinic Taussig Cancer Institute Case Comprehensive Cancer Center, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 1. 7. 2026. · NCT07079631

The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors

Тражи се учесникОпсервациона студија
  • University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 9. 4. 2026. · NCT04624555

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

Тражи се учесникФаза 1/2
  • Cleveland Clinic, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 18. 2. 2026. · NCT07030257

A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

Тражи се учесникФаза 1/2
  • Cleveland Clinic, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 25. 11. 2024. · NCT05824975

Studije za Колоректални карцином u drugim gradovima

Ostale studije u gradu Cleveland

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.